Core Insights - Cuprina Holdings has signed a Memorandum of Understanding (MOU) with Singapore Biowaste Solutions to explore the integration of its medical waste recycling technology into SBS's waste management facility in Singapore [1][2][3] Company Overview - Cuprina Holdings is a biomedical company focused on developing and marketing products for chronic wounds, infertility, and cosmeceuticals [1][6] - Singapore Biowaste Solutions is recognized as Singapore's most advanced provider for biomedical waste disposal and management [7] Collaboration Details - The collaboration aims to reduce reliance on incineration and landfilling, enhance recycling efficiency, and unlock new revenue streams from recycled materials [2][5] - Cuprina will provide technical expertise, training, and support for a feasibility study and pilot program at SBS's facility [3][4] - SBS will contribute operational data, facility access, and regulatory support to ensure compliance with Singapore's environmental standards [4] Technology and Innovation - Cuprina's technology involves a high-temperature steam process known as autoclaving, which sterilizes, decontaminates, and recycles plastic-based medical waste into high-value resins [3] - This technology has been developed under the oversight of the United Nations Industrial Development Organization (UNIDO) and the Global Environment Facility (GEF) [3] Future Prospects - The companies plan to develop revenue-sharing models for the integrated process and explore expansion opportunities across Southeast Asia [5] - Cuprina's CEO expressed optimism that the integrated recycling technology could secure necessary regulatory approvals and commence operations by the end of 2026 [5]
Cuprina Signs MOU with Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies